Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”) today announced the commercial launch and first enterprise deployment of Volato AI, its purpose-built enterprise artificial intelligence platform for business aviation. Flyte, a technology-enabled regional air mobility company owned by Catheter Precision, Inc. (NYSE American: VTAK), will serve as the platform’s inaugural enterprise customer.
Volato Group, Inc. (NYSE American: SOAR) (the “Company”) today announced that Vaunt has successfully completed its first international member flight, marking the platform's expansion beyond the United States and establishing the foundation for future international growth.
Volato Group, Inc. (NYSE American: SOAR) (the “Company”) today provided a preliminary financial and operating update for the second quarter ended June 30, 2026. Based on currently available information, the Company expects to report the following preliminary second quarter highlights:
Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”) today announced the closing of a $2.2 million private investment in public equity (“PIPE”) financing priced at $0.34 per share.
Volato Group, Inc. (NYSE American: SOAR) (“Volato” or the “Company”) today announced that it continues to evaluate multiple unsolicited, non-binding letters of intent related to potential strategic transactions in AI infrastructure and related sectors. The Company also reported that Vaunt annual recurring revenue (“ARR”) reached approximately $4.0 million as of May 2026, representing approximately 221% year-over-year growth.
Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced the signing of a definitive agreement to obtain a $2.2 million strategic investment lead by Catheter Precision, Inc. (NYSE American: VTAK), and other institutional investors with experience investing in artificial intelligence and emerging technology companies.
Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”), a technology company focused on building scalable software and data solutions that improve the reliability and intelligence of high-stakes business decisions, today announced that it has received notice from NYSE Regulation that NYSE American LLC ("NYSE American") has accepted the Company's plan to regain compliance with the NYSE American continued listing standards. The acceptance allows Volato’s Class A common stock to continue trading on NYSE American while the Company executes its plan and continues its broader financial and strategic stabilization efforts.
Aurica to License the Platform for 60 Million Tokens to Power the First Gold Token Built on Coupon Token Architecture; Companies Target Fourth Quarter 2026 Launch
IGC Pharma, Inc. (NYSE: IGC), a clinical-stage AI biotechnology company focused on Alzheimer’s disease, is gaining investor attention after CEO Ram Mukunda appeared on Bloomberg TV discussing the company’s lead drug candidate, IGC-AD1, a potential fast-acting therapy for agitation associated with Alzheimer’s dementia .
Volato Group Inc (NYSE American: SOAR) stock surges over 110% on Monday after merger partner M2i Global signs an LOI for physically-backed gold tokenization.
Volato Group, Inc. (NYSE American: SOAR) (the “Company” or “Volato”) today announced that Vaunt, its experiential private aviation platform, reached approximately $3.6 million in annual recurring revenue (“ARR”) as of April 30, 2026, representing continued growth following the platform’s previously announced $3.0 million ARR milestone in the first quarter of 2026.
